We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.41 | 14.04 | 14.78 | 55,875 | 08:01:56 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 13.24 | 3.92B |
TIDMGLB
RNS Number : 4206E
Glanbia PLC
10 March 2022
Annual Financial Report
10 March 2022
Glanbia plc ("Glanbia", the "Group", the "Company", the "plc"), the global nutrition group, announces that the Annual Report and Financial Statements for the year ended 1 January 2022 (ESEF compliant format) is available from today on the Company's website, and may be viewed and downloaded online at:
https://www.glanbia.com/annualreport2021
The Annual Report has been submitted to Euronext Dublin and the UK National Storage Mechanism and will shortly be available for inspection at:-
Euronext Dublin OAM Filing
and at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The Annual Report will be posted to shareholders who have elected to receive them and will also be available from the Group Secretary at the Company's registered office at Glanbia House, Kilkenny, R95 E866.
Contact details
Investors
Liam Hennigan, Group Director, Strategic Planning & Investor Relations: +353 86 046 8375
Media
Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACSFLFITVDIILIF
(END) Dow Jones Newswires
March 10, 2022 13:10 ET (18:10 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions